ArticleOncology and therapy2025

Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung Cancer.

Myung-Ju Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.